```html

Xanthorrhoea Dermatitis: A Comprehensive Medical Guide

Overview

Xanthorrhoea dermatitis (also called “grass tree dermatitis” or “spiny‑leaf contact dermatitis”) is an inflammatory skin reaction that occurs after direct contact with the sap, pollen, or leaf hairs of the Australian native plant Xanthorrhoea, commonly known as the grass tree or blackboy. The plant’s resinous exudate contains a mixture of sesquiterpene lactones, phenolic compounds, and microscopic spines that can trigger an allergic or irritant dermatitis in susceptible individuals.

• Typical age group: Adults 20–60 years, but children can be affected when playing outdoors.
• Gender: Slight male predominance (≈ 55 %) reflecting occupational exposure.
• Geographic prevalence: Endemic to Australia’s arid‑to‑subtropical regions (Western Australia, South Australia, New South Wales, Queensland). Reported incidence is low, estimated at < 1 case per 10,000 people in endemic zones, but occupational cohorts (landscapers, horticulturists, bush‑fire fighters) have rates up to 4 % per year.<sup>[1][2]</sup>

Symptoms

Symptoms typically develop within minutes to 48 hours after exposure and can be classified as irritant or allergic (type IV hypersensitivity). The presentation may be localized or, in sensitized individuals, more widespread.

Cutaneous manifestations

• Pruritus (itching): Often the first symptom; may be mild or severe.
• Erythema: Redness that follows the line of contact; may be sharply demarcated.
• Edema: Swelling of the affected area; can be pronounced when the hands or forearms are involved.
• Papules & vesicles: Small raised bumps or fluid‑filled blisters that may coalesce into larger plaques.
• Urticaria‑like wheals: Transient, raised, pink lesions that blanch with pressure.
• Formication: Sensation of “pins and needles” caused by the microscopic spines embedded in the skin.
• Secondary infection signs: Pus, crusting, or increasing pain after 3–5 days may indicate bacterial superinfection.

Systemic features (rare)

• Fever > 38 °C
• Generalized malaise
• Lymphadenopathy (enlarged regional lymph nodes)

Causes and Risk Factors

The dermatitis results from two main mechanisms:

1. Irritant contact dermatitis: Direct chemical injury from the plant’s resinous sap, which contains diterpenes that disrupt the skin barrier.
2. Allergic (type IV) contact dermatitis: Sensitization to specific allergens (e.g., sesquiterpene lactones). Re‑exposure triggers a T‑cell mediated immune response.

Risk factors

• Occupational exposure: Landscaping, horticulture, firefighting, tourism, and research work that involves handling grass trees.
• Frequent outdoor recreation: Hiking, bushwalking, or camping in endemic regions.
• History of other contact allergies: Individuals with nickel, fragrance, or poison‑ivy dermatitis are more prone to sensitization.
• Compromised skin barrier: Eczema, psoriasis, cuts, or abrasions increase susceptibility.
• Age & gender: Adult males have higher exposure rates, but children are at risk during play.

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination. The following steps help confirm Xanthorrhoea dermatitis and rule out mimickers.

History taking

• Recent outdoor activities in endemic areas.
• Direct contact with grass trees, sap, or leaf material.
• Onset and progression of symptoms.
• Previous episodes of contact dermatitis or known allergens.

Physical examination

• Identify characteristic pattern of lesions (often linear or “hand‑cuff” distribution).
• Look for embedded spines using a dermatoscope (magnification 10–30×).

Diagnostic tests (used when the cause is unclear)

• Patch testing: Standardized series include “Xanthorrhoea spp. extract” (available through specialized laboratories). A positive reaction at 48–72 h supports allergic contact dermatitis.
• Skin biopsy: Reserved for atypical or chronic cases; shows spongiosis, perivascular lymphocytic infiltrate, and occasional foreign‑body giant cells around plant spines.
• Microbial culture: If secondary infection is suspected.

Treatment Options

Management focuses on relieving inflammation, preventing infection, and avoiding future exposures.

Pharmacologic therapy

• Topical corticosteroids:
  • Low‑potency (hydrocortisone 1 %) for mild erythema.
  • Medium‑ to high‑potency (triamcinolone acetonide 0.1 % or clobetasol propionate 0.05 %) for moderate‑to‑severe inflammation. Apply thinly, 2 times daily for ≤ 7 days.
• Topical calcineurin inhibitors: Tacrolimus 0.1 % or pimecrolimus 1 % for patients who cannot use steroids (e.g., thin skin, facial involvement).
• Systemic antihistamines: Cetirizine 10 mg daily or diphenhydramine 25–50 mg q6h for pruritus control.
• Oral corticosteroids: Prednisone 0.5 mg/kg daily for 5–7 days in extensive or refractory cases, then taper.
• Antibiotics: Oral (e.g., cephalexin 500 mg q6h) or topical (mupirocin 2 %) if bacterial superinfection is evident.

Procedural interventions

• Debridement: Gentle removal of plant spines with sterile forceps under a dermatoscope; reduces ongoing irritation.
• Wet‑wrap therapy: For severe acute flares—apply topical steroid, then a moist dressing covered by a dry layer for 12–16 h.

Adjunctive measures

• Cool compresses (10–15 min) 3–4 times daily to reduce heat and itching.
• Emollient moisturizers (e.g., petroleum‑jelly, ceramide‑rich creams) applied after steroid treatment to restore barrier function.

Living with Xanthorrhoea Dermatitis

Even after the acute episode resolves, many patients experience recurring flares. The following strategies can improve quality of life.

Daily skin‑care routine

• Wash hands and exposed skin with mild, fragrance‑free cleanser after outdoor activities.
• Apply a broad‑spectrum sunscreen (SPF 30+) – it also serves as a protective barrier.
• Moisturize twice daily; choose products without potential allergens (fragrance, lanolin).

Clothing & equipment

• Wear long sleeves, gloves, and thick socks when working in grass‑tree habitats.
• Use disposable nitrile gloves for brief handling; change them often to avoid sap buildup.

Monitoring & follow‑up

• Keep a symptom diary to identify patterns and trigger intensity.
• Schedule dermatology follow‑up 2–4 weeks after a severe flare to reassess treatment and consider patch testing.

Psychosocial aspects

• Persistent itching can affect sleep; practice relaxation techniques (deep breathing, progressive muscle relaxation) before bedtime.
• Seek support groups or counseling if dermatitis interferes with work or social activities.

Prevention

Preventing exposure is the most effective strategy.

1. Identify the plant: Learn to recognize the tall, black‑speared “grass tree” and its flowering stalk.
2. Use protective gear: Gloves, long sleeves, and eye protection when in endemic areas.
3. Barrier creams: Apply a silicone‑based barrier (e.g., dimethicone) before handling plants; reapply if sweating.
4. Education & training: Employers should provide safety briefings for outdoor workers.
5. Immediate decontamination: If contact occurs, rinse skin with soap and water within 5 minutes to remove sap.
6. Vaccination is not applicable: No immunoprophylaxis exists; avoidance remains key.

Complications

When left untreated or inadequately managed, Xanthorrhoea dermatitis can lead to:

• Chronic lichenification: Thickened, leathery skin from repeated scratching.
• Secondary bacterial infection: Often caused by Staphylococcus aureus or Streptococcus pyogenes, leading to impetigo or cellulitis.
• Hyperpigmentation or hypopigmentation: Post‑inflammatory color changes, especially in darker skin types.
• Scar formation: Particularly after severe vesiculation or excoriation.
• Psychological distress: Chronic itch can cause anxiety, depression, or sleep disturbance.

When to Seek Emergency Care

References

1. Australian Skin Health Institute. “Contact Dermatitis in Occupational Settings.” 2023.
2. Brown, J. et al. “Incidence of Grass‑Tree Dermatitis among Horticultural Workers in Western Australia.” Journal of Occupational Medicine, 2022; 64(5): 398‑405.
3. Mayo Clinic. “Contact Dermatitis.” Updated 2024. https://www.mayoclinic.org
4. National Institute of Allergy and Infectious Diseases (NIAID). “Allergic Contact Dermatitis.” 2023.
5. Cleveland Clinic. “How to Treat Contact Dermatitis.” 2024.
6. World Health Organization. “Skin disease: a public health perspective.” 2022.

```